PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (S)-(-)-1-(1-Naphthyl)ethylamine (2R,3R)-2,3-dihydroxybutanedioic salt | 600-817-8 | 1073145-07-9 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-(-)-1-Phenylpropylamine | 609-485-9 | 3789-59-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-(-)-tetrahydro-2-furoic acid | 433-770-5 | - | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-1-(p-tolyl)ethanamine | 623-635-0 | 27298-98-2 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-2,2,4-trimethylpyrrolidine hydrochloride | 943-629-4 | 1897428-40-8 | - | - | - | - | 1 | - | - | - | - | Details |
|
(S)-2-chloropropionic acid
L-2-CHLOROPROPIONIC ACID; L-2-CHLORPROPIONSÄURE
|
411-150-5 | 29617-66-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-one | 218-827-2 | 2244-16-8 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-3-(tert-butylamino)propane-1,2-diol | 250-125-1 | 30315-46-9 | - | - | - | - | 1 | - | - | - | - | Details |
|
(S)-methyl-2-chloropropionate
L (-) CHLOROPROPIONATE DE METHYLE; S (-) CHLOROPROPIONATE DE METHYLE
|
412-470-8 | 73246-45-4 | - | - | - | - | 1 | - | - | - | - | Details |
| (S)-propane-1,2-diamine bis((2S,3S)-2,3-dihydroxysuccinate) dihydrate | 924-425-4 | - | - | - | - | - | 1 | - | - | - | - | Details |
| (S,S)-Ethylenediamine-N,N'-disuccinic acid trisodium salt | 605-842-8 | 178949-82-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (T4)-Aluminate(1-), bis[P,P'-dimethyldiphosphonato(2-)-ĸO,ĸO’]-, hydrogen (1:1) | 861-799-7 | 2241885-74-3 | - | - | 1 | - | - | - | - | - | - | Details |
| (tert-butoxymethyl)oxirane | 231-640-0 | 7665-72-7 | - | - | - | - | 1 | - | - | - | - | Details |
| (tetrapropenyl)succinic acid | 248-698-8 | 27859-58-1 | - | - | 2 | - | - | - | - | - | - | Details |
|
(trans(trans))-4'-but-3-enyl-4-(4-methylphenyl)-bicyclohexyl
1-(TRANS,TRANS-4'-(3-BUTENYL)-BICYCLOHEXYL-4-YL)-4-METHYLBEN
|
429-580-7 | - | - | - | - | - | 1 | - | - | - | - | Details |
|
(trans(trans))-4'-vinyl-4-(4-methylphenyl)bicyclohexyl
LICRISTAL CCP-V-1
|
439-730-3 | - | - | - | 2 | - | 1 | - | - | - | - | Details |
| (undec-10-enoylamino)acetic acid | 427-430-5 | 54301-26-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
| (xylenes and 4-ethylbenzene)sulfonic acids | 701-247-3 | - | - | - | 2 | - | - | - | - | - | - | Details |
| (Z)-13-octadecenal | 261-349-4 | 58594-45-9 | - | - | - | - | - | 1 | - | - | - | Details |
| (Z)-2-butene-1,4-diol | 228-085-1 | 6117-80-2 | - | - | 2 | - | - | - | - | - | - | Details |
| (Z)-3-hexenyl salicylate | 265-745-8 | 65405-77-8 | - | - | 2 | - | 1 | - | - | - | - | Details |
| (Z)-4-[C11-13 (branched) alkylamino]-4-oxo-2-butenoic acid | 701-116-0 | - | - | - | 3 | - | - | - | - | - | - | Details |
|
(Z)-9-Octadecen-1-ol ethoxylated
1 - 2.5 moles ethoxylated
|
500-016-2 | 9004-98-2 | - | - | 1 | - | - | - | - | - | - | Details |
| (Z)-[(octadec-9-enyloxy)methyl]oxirane | 262-268-7 | 60501-41-9 | - | - | - | - | 1 | - | - | - | - | Details |
| (Z)-cyclooctene | 213-243-4 | 931-87-3 | - | - | 1 | - | 1 | - | - | - | - | Details |